Events

Companies Presenting Exosome Data at AACR

exosomes

Panacea Pharmaceuticals, Inc. Presents Data That Its Cancer Biomarker HAAH is Readily Detectable in Serum Exosomes Improved Detection of Exosomal HAAH is Presented at the American Association for Cancer Research (AACR) Meeting in Washington, DC, April 2, 2017 GAITHERSBURG, Md., ...

Read More »

Exosomes and Liquid Biopsies Asia 2017

exosomes

Welcome to Select Biosciences, Inc. Second Annual Exosomes and Liquid Biopsies Asia 2017.  This conference is being held in one of the hubs of trade and commerce in Asia — Taipei, Taiwan.  Just a short flight from most business destinations ...

Read More »

Upcoming Symposium – Exosomes in the CNS

exosomes

Tuesday, March 21, 2017 | 12:00 PM – 5:00 PM The New York Academy of Sciences Presented by the Biochemical Pharmacology Discussion Group Extracellular vesicles have experienced increasing attention in recent years, as our understanding of the diversity of their ...

Read More »

Circulating Biomarkers World Congress 2017

exosome rna

Select Biosciences, Inc. Fourth Annual Circulating Biomarkers World Congress 2017 brings together the most up-to-date technologies and advances in this expanding and evolving field.  Our coverage in this conference focuses on the various classes of circulating biomarkers: Extracellular Vesicles (EVs): ...

Read More »

The Liquid Biopsy Summit 2017

exosome rna

This is an unprecedented time in biomolecular medicine. 1) Recent scientific findings have determined biofluids consist of circulating tumor cells (CTCs), cell-free nucleic acid (cfNA), or extracellular vesicles from multiple tissues within the body. 2) Rapid development of highly sensitive ...

Read More »

Upcoming Event – Exosomes in the CNS

exosomes

Tuesday, March 21, 2017 | 12:00 PM – 5:00 PM The New York Academy of Sciences Presented by the Biochemical Pharmacology Discussion Group Extracellular vesicles have experienced increasing attention in recent years, as our understanding of the diversity of their ...

Read More »